Wellington Management Group
BHVN

Wellington Management Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Wellington Management Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,280
Closed -$2.01M – 2204
2022
Q3 		$2.01M Buy
13,280
+2,296
+21% +$340K ﹤0.01% 1526
2022
Q2 		$1.6M Sell
10,984
-124,300
-92% -$15.9M ﹤0.01% 1584
2022
Q1 		$16M Buy
135,284
+33,437
+33% +$4.17M ﹤0.01% 1072
2021
Q4 		$14M Buy
101,847
+815
+0.8% +$104K ﹤0.01% 1165
2021
Q3 		$14M Sell
101,032
-175,810
-64% -$22M ﹤0.01% 1174
2021
Q2 		$26.9M Sell
276,842
-1,538,512
-85% -$125M ﹤0.01% 1019
2021
Q1 		$124M Buy
1,815,354
+229,102
+14% +$18.5M 0.02% 544
2020
Q4 		$136M Sell
1,586,252
-754,357
-32% -$63.9M 0.03% 507
2020
Q3 		$152M Buy
2,340,609
+257,228
+12% +$16.9M 0.03% 436
2020
Q2 		$152M Sell
2,083,381
-1,034,992
-33% -$55.1M 0.03% 419
2020
Q1 		$106M Buy
3,118,373
+1,578,708
+103% +$72.2M 0.03% 445
2019
Q4 		$83.8M Buy
1,539,665
+147,145
+11% +$7.29M 0.02% 611
2019
Q3 		$58.1M Buy
1,392,520
+420,799
+43% +$17.8M 0.01% 688
2019
Q2 		$42.5M Sell
971,721
-413,045
-30% -$23.3M 0.01% 802
2019
Q1 		$71.3M Sell
1,384,766
-191,658
-12% -$8.28M 0.02% 641
2018
Q4 		$58.3M Buy
1,576,424
+379,374
+32% +$13.7M 0.01% 675
2018
Q3 		$44.9M Buy
1,197,050
+113,327
+10% +$4.17M 0.01% 836
2018
Q2 		$42.8M Buy
1,083,723
+2,659
+0.2% +$84.4K 0.01% 842
2018
Q1 		$27.8M Buy
1,081,064
+562,633
+109% +$16.8M 0.01% 961
2017
Q4 		$14M Sell
518,431
-307,014
-37% -$8.45M ﹤0.01% 1171
2017
Q3 		$30.9M Buy
825,445
+469,338
+132% +$14.2M 0.01% 912
2017
Q2 		$8.9M Buy
+356,107
New +$8.2M ﹤0.01% 1251

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Wellington Management Group's BHVN Position: Q4 2022 in Review

Wellington Management Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 13,280 shares — an estimated $2.01M sold.

Wellington Management Group first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $152M in Q2 2020. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Wellington Management Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Wellington Management Group sold 13,280 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $2.01M.
  • Wellington Management Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Wellington Management Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $152M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.